New healthcare fund could benefit device ventures:
This article was originally published in Clinica
A $900m healthcare fund for companies in the US, Europe and Asia was set up last month by investment management firm MPM Capital of Boston, Massachusetts. While the lion's share of the funds will be made available to companies with potential to develop new drugs, some will be invested in developers of early genomics or proteomics technology, and medical device ventures will also be targeted. Investments will be up to $60m per company, with a preferred investment size of $15-25m.